Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells.

@article{Kihara1998TroglitazoneEG,
  title={Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells.},
  author={Shinji Kihara and Noriyuki Ouchi and Tohru Funahashi and Eiko Shinohara and Ritsu Tamura and Shizuya Yamashita and Yuji Matsuzawa},
  journal={Atherosclerosis},
  year={1998},
  volume={136 1},
  pages={163-8}
}
The thiazolidinedione analogue troglitazone is an antidiabetic agent that improves insulin resistance in rodents and humans. Although coronary artery disease is common in patients with the insulin resistance syndrome, the effects of troglitazone on smooth muscle cells (SMC) have not been fully elucidated. We therefore examined the effects of troglitazone on… CONTINUE READING